The MarketWatch News Department was not involved in the creation of this content.
Dublin, Sep 17, 2020 (GLOBE NEWSWIRE via COMTEX) —
Dublin, Sept. 17, 2020 (GLOBE NEWSWIRE) — The “Cryptococcosis Treatment Market Research Report by Treatment (Amphotericin B, Fluconazole, and Flucytosine), by Distribution (Hospital Pharmacies, Mail Order Pharmacies, and Retail Pharmacies & Drug Stores) – Global Forecast to 2025 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering.
The Global Cryptococcosis Treatment Market is expected to grow from USD 5,959.88 Million in 2019 to USD 7,923.56 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 4.86%.
The Flucytosine is projected to witness the highest growth during the forecast period
Based on Treatment, the Cryptococcosis Treatment Market studied across Amphotericin B, Fluconazole, and Flucytosine. The Fluconazole commanded the largest size in the Cryptococcosis Treatment Market in 2019. On the other hand, the